The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Detection of Renal Function Decline in Patients with Diabetes and Normal or Elevated GFR by Serial Measurements of Serum Cystatin C Concentration: Results of a 4-Year Follow-Up Study
Open accessAbstract
Research on early renal function decline in diabetes is hampered by lack of simple tools for detecting trends (particularly systematic decreases) in renal function over time when GFR is normal or elevated. This study sought to assess how well serum cystatin C meets that need. Thirty participants with type 2 diabetes in the Diabetic Renal Disease Study met these three eligibility criteria: GFR >20 ml/min per 1.73 m2 at baseline (based on cold iothalamate clearance), 4 yr of follow-up, and yearly measurements of iothalamate clearance and serum cystatin C. With the use of linear regression, each individual's trend in renal function over time, expressed as annual percentage change in iothalamate clearance, was determined. Serum cystatin C in mg/L was transformed to its reciprocal (100/cystatin C), and linear regression was used to determine each individual's trend over time, expressed as annual percentage change. In paired comparisons of 100/cystatin C with iothalamate clearance at each examination, the two measures were numerically similar. More important, the trends in 100/cystatin C and iothalamate clearance were strongly correlated (Spearman r = 0.77). All 20 participants with negative trends in iothalamate clearance (declining renal function) also had negative trends for 100/cystatin C. Results were discordant for only three participants. In contrast, the trends for three commonly used creatinine-based estimates of GFR compared poorly with trends in iothalamate clearance (Spearman r < 0.35). Serial measures of serum cystatin C accurately detect trends in renal function in patients with normal or elevated GFR and provide means for studying early renal function decline in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Self-citationSerum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis
Dharnidharka, V. R., Kwon, C., & Stevens, G. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34487 · Cited by 1,663
Longitudinal Studies on the Rate of Decline in Renal Function with Age
Lindeman, R. D., Tobin, J., & Shock, N. W. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb07117.x · Cited by 1,578
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Knight, E. L., Verhave, J. C., Spiegelman, D., Hillege, H. L., De Zeeuw, D., Curhan, G. C., & De Jong, P. E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00517.x · Cited by 1,039
Cystatin C: An Improved Estimator of Glomerular Filtration Rate?
Laterza, O. F., Price, C. P., & Scott, M. G. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.5.699 · Cited by 658
Hoek, F. J. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg349 · Cited by 564
Nelson, R. G., Bennett, P. H., Beck, G. J., Tan, M., Knowler, W. C., Mitch, W. E., Hirschman, G. H., & Myers, B. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352203 · Cited by 477
Self-citation
Cited by
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
“However, a number of studies demonstrated that impaired GFR can occur without substantial albuminuria and that DKD can manifest solely as impaired GFR.(37-41) Our study suggests that the clinical pattern of DKD may be shifting over time, with more impaired GFR and the possibility of decreased albuminuria, which could…”
BackgroundGlomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Bommel, E. J., Heerspink, H. J. L., van Raalte, D. H., & Joles, J. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060666 · Cited by 887
“…on the basis of serum cystatin C is suggested to more accurately re fl ect renal function in patients with diabetes and normal or elevated GFR. 17,18 Never-theless, renal clearance techniques using inulin, or its more widely used alternative sinistrin, are required for gold standard measurement…”
Shlipak, M. G., Katz, R., Sarnak, M. J., Fried, L. F., Newman, A. B., Stehman-Breen, C., Seliger, S. L., Kestenbaum, B., Psaty, B., Tracy, R. P., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00003 · Cited by 540
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
MacIsaac, R. J., Ekinci, E. I., & Jerums, G. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.048 · Cited by 378
Microalbuminuria and the Risk for Early Progressive Renal Function Decline in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., & Krolewski, A. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080872 · Cited by 370
Self-citationCirculating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Gohda, T., Niewczas, M. A., Ficociello, L. H., Walker, W. H., Skupien, J., Rosetti, F., Cullere, X., Johnson, A. C., Crabtree, G., Smiles, A. M., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060628 · Cited by 356
Self-citationIx, J. H., Shlipak, M. G., Chertow, G. M., & Whooley, M. A. (2007) · Circulation · doi:10.1161/circulationaha.106.644286 · Cited by 326
Epidemiology of Diabetic Kidney Disease
Reutens, A. T. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.10.001 · Cited by 326
Estimated GFR: time for a critical appraisal
Porrini, E., Ruggenenti, P., Luis-Lima, S., Carrara, F., Jiménez, A., de Vries, A. P. J., Torres, A., Gaspari, F., & Remuzzi, G. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0080-9 · Cited by 294
Perkins, B. A., Ficociello, L. H., Roshan, B., Warram, J. H., & Krolewski, A. S. (2010) · Kidney International · doi:10.1038/ki.2009.399 · Cited by 289
Self-citationUpdate on Cystatin C: Incorporation Into Clinical Practice
Shlipak, M. G., Mattes, M. D., & Peralta, C. A. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.027 · Cited by 283
New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
Sandholm, N., Salem, R. M., McKnight, A. J., Brennan, E. P., Forsblom, C., Isakova, T., McKay, G. J., Williams, W. W., Sadlier, D. M., Mäkinen, V.-P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002921 · Cited by 278
Self-citationKrolewski, A. S., Niewczas, M. A., Skupien, J., Gohda, T., Smiles, A., Eckfeldt, J. H., Doria, A., & Warram, J. H. (2014) · Diabetes Care · doi:10.2337/dc13-0985 · Cited by 276
Self-citationChange in Estimated GFR Associates with Coronary Heart Disease and Mortality
Matsushita, K., Selvin, E., Bash, L. D., Franceschini, N., Astor, B. C., & Coresh, J. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010025 · Cited by 276
How to estimate GFR-serum creatinine, serum cystatin C or equations?
Herget-Rosenthal, S., Bökenkamp, A., & Hofmann, W. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.10.014 · Cited by 268
Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis
Tziomalos, K., & Athyros, V. G. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.110 · Cited by 268
Thompson, D. M., Meloche, M., Ao, Z., Paty, B., Keown, P., Shapiro, R. J., Ho, S., Worsley, D., Fung, M., Meneilly, G., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e31820437f3 · Cited by 213
“Direct measurement of GFR is superior to estimates based on serum creatinine in clinical trials (46), especially in patients with normal GFR (47) and those with diabetes (48).”
MethodAssociation of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics
Wolkow, P. P., Niewczas, M. A., Perkins, B., Ficociello, L. H., Lipinski, B., Warram, J. H., & Krolewski, A. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050556 · Cited by 155
Self-citationOdden, M. C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.20.2213 · Cited by 124
Peralta, C. A., Vittinghoff, E., Bansal, N., Jacobs, D., Muntner, P., Kestenbaum, B., Lewis, C., Siscovick, D., Kramer, H., Shlipak, M., et al. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.01.012 · Cited by 74
Orlov, S., Cherney, D. Z. I., Pop-Busui, R., Lovblom, L. E., Ficociello, L. H., Smiles, A. M., Warram, J. H., Krolewski, A. S., & Perkins, B. A. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11441114 · Cited by 57
Self-citation
Metadata
- Authors
- Perkins, B. A., Nelson, R. G., Ostrander, B. E. P., Blouch, K. L., Krolewski, A. S., Myers, B. D., & Warram, J. H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-05
- Volume
- 16
- Issue
- 5
- Pages
- 1404-1412
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2105258594
- Cited by
- 323
- References
- 32
- FWCI
- 18.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.